FLGC

Flora Growth Corp

FLGC, USA

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in two segments: Commercial and Wholesale, House of Brands. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products. The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs. In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. Further, the company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is headquartered in Fort Lauderdale, Florida.

https://www.floragrowth.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
FLGC
stock
FLGC

(FLGC) Volatility Zones as Tactical Triggers Stock Traders Daily

Read more →
FLGC
stock
FLGC

Flora Growth (NASDAQ:FLGC) Upgraded to “Hold” at Wall Street Zen Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$30

Analyst Picks

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.06

Low 1

High 3

Return on Equity (ROE)

-

Very Low

-10.26 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-9.00 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-3.18 %

Low 5%

High 15%

Debt to Equity

-

Very High

0.14

Low 1

High 0.3

Investors

* Institutions hold a combined 3.87% of the total shares of Flora Growth Corp

1.

Geode Capital Management, LLC

(0.7336%)

since

2025/03/31

2.

Vanguard Institutional Extnd Mkt Idx Tr

(0.6406%)

since

2025/07/31

3.

Vanguard Group Inc

(0.3934%)

since

2025/03/31

4.

Fidelity Extended Market Index

(0.3852%)

since

2025/07/31

5.

Renaissance Technologies Corp

(0.3634%)

since

2025/03/31

6.

AdvisorShares Investments, LLC

(0.3144%)

since

2025/06/30

7.

State Street Corp

(0.1622%)

since

2025/03/31

8.

XTX Topco Ltd

(0.1042%)

since

2025/03/31

9.

Fidelity Total Market Index

(0.0888%)

since

2025/07/31

10.

Fidelity Series Total Market Index

(0.0881%)

since

2025/07/31

11.

Spartan Extended Market Index Pool F

(0.0774%)

since

2025/07/31

12.

UBS Group AG

(0.0768%)

since

2025/03/31

13.

Fidelity Nasdaq Composite Index

(0.0733%)

since

2025/07/31

14.

Northern Trust Corp

(0.0727%)

since

2025/03/31

15.

Northern Trust Extended Eq Market Idx

(0.0727%)

since

2025/06/30

16.

NT Ext Equity Mkt Idx Fd - L

(0.0727%)

since

2025/06/30

17.

Morgan Stanley - Brokerage Accounts

(0.0522%)

since

2025/03/31

18.

Spartan Total Market Index Pool G

(0.0454%)

since

2025/07/31

19.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0205%)

since

2025/06/30

20.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0173%)

since

2024/12/31

21.

Royal Bank of Canada

(0.0033%)

since

2025/03/31

22.

Sound Income Strategies

(0.0022%)

since

2025/06/30

23.

Advisor Group Holdings, Inc.

(0.0017%)

since

2025/03/31

24.

Barclays PLC

(0.0014%)

since

2025/03/31

25.

Bank of America Corp

(0.0008%)

since

2025/03/31

26.

Fidelity U.S. Equity Index Ins Trust

(0.0004%)

since

2025/07/31

27.

Wells Fargo & Co

(0.0003%)

since

2025/03/31

28.

BlackRock Inc

(0.0001%)

since

2025/03/31

29.

IFP Advisors, LLC

(0.0001%)

since

2025/06/30

30.

SBI Securities Co Ltd

(0%)

since

2025/03/31

32.

Toth Financial Advisory Corp

(0%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

EPS Estimate

Latest Release

Date

2025-09-30

EPS Actual

-9.0476

EPS Estimate

-2.13

EPS Difference

-6.9176

Surprise Percent

-324.77%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
Strong Momentum(7)
Net Net
Possible Net-Net(5.5)
Quality
Low Quality Business(3)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.